pp 1-10 | Cite as

Serum Diamine Oxidase in Pseudoallergy in the Pediatric Population

  • Joanna Kacik
  • Barbara Wróblewska
  • Sławomir Lewicki
  • Robert Zdanowski
  • Bolesław Kalicki
Chapter
Part of the Advances in Experimental Medicine and Biology book series

Abstract

Histamine intolerance (pseudoallergy) is a poorly investigated type of food hypersensitivity. The main enzyme responsible for histamine degradation in the extracellular matrix is diamine oxidase (DAO). Disturbances in the concentration or activity of DAO may lead to the development of clinical signs of allergy. The aim of the present work was to assess the DAO concentration, peripheral blood morphology, lymphocytes phenotyping (CD3+, CD4+, CD8+, CD19+, NK cells, NKT cells, and activated T-cells), and natural regulatory Treg (nTregs) cell population (CD4+, CD25+, CD127low, and FoxP3) in 34 pediatric patients with histamine-dependent syndromes. Patients were divided into two groups: classical allergy and pseudoallergy on the basis of IgE concentration. The investigation was based on the analysis of peripheral blood samples. A significantly lower serum DAO, both total and specific IgE, concentration was found in the pseudoallergy group compared with the allergy group. There were no significant differences in blood morphology or lymphocyte populations. A similar level of nTreg lymphocytes was also found in both groups, although it was lower than that present in healthy individuals. The findings suggest that the serum DAO is responsible for the symptoms of histamine intolerance. Moreover, a general decrease in nTreg cells in comparison with healthy individuals may lead to symptom aggravation.

Keywords

Allergy Angioedema Dermal lesions Headache Immunological disorders Stomachache 

References

  1. Akin C, Scott LM, Kocabas CN, Kushnir-Sukhov N, Brittain E, Noel P, Metcalfe DD (2007) Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with ‘idiopathic’ anaphylaxis. Blood 110(7):2331–2333CrossRefPubMedPubMedCentralGoogle Scholar
  2. Czerwionka-Szaflarska M, Zielińska-Duda H (2009) Allergy and food intolerance in children. Fam Med Prim Care Rev 11:577–584Google Scholar
  3. Górski P (2007) Histamine- a mediator the longer known the more unknown. Alergia 4:33–35Google Scholar
  4. Hoffmann KM, Gruber E, Deutschmann A, Jahnel J, Hauer AC (2013) Histamine intolerance in children with chronic abdominal pain. Arch Dis Child 98(10):832–833CrossRefPubMedGoogle Scholar
  5. Høst A, Andrae S, Charkin S, Diaz-Vázquez C, Dreborg S, Eigenmann PA, Friedrichs F, Grinsted P, Lack G, Meylan G, Miglioranzi P, Muraro A, Nieto A, Niggemann B, Pascual C, Pouech MG, Rancé F, Rietschel E, Wickman M (2003) Allergy testing in children: why, who, when and how. Allergy 58(7):559–569CrossRefPubMedGoogle Scholar
  6. Jarisch R (2004) Histamin-Intoleranz. Histamin und Seekrankheit, 2nd edn. Georg Thieme Verlag, Stuttgart/New YorkGoogle Scholar
  7. Kalicki B, Lewicki S, Stankiewicz W, Jung A, Rustecka A, Turkowska M, Rutkowski P, Bodera P, Zdanowski R (2013) Examination of correlation between vitamin D-3 (25-OHD3) concentration and percentage of regulatory T lymphocytes (FoxP3) in children with allergy symptoms. Cent Eur J Immunol 38(1):70–75CrossRefGoogle Scholar
  8. Karpińska-Gasztoł E, Gutowska M, Zdunowski P, Zgliczyńskiet W (2014) Plethoric facies – multidisciplinary problem. Histamine intolerance secondary to reduced diamine oxidase activity. Post N Med 27(12):843–846. (Article in polish)Google Scholar
  9. Kofler L, Umler H, Kofler H (2011) Histamine 50-skin-prick test: a tool to diagnose histamine intolerance. ISNR Allergy 2011:353045. doi:10.5402/2011/353045 Google Scholar
  10. Kovacova-Hanuskova E, Buday T, Gavliakova S, Plevkova J (2015) Histamine, histamine intoxication and intolerance. Allergol Immunopathol (Madr) 43(5):498–506CrossRefGoogle Scholar
  11. Lessof MH, Gant V, Hinuma K, Murphy GM, Dowling RH (1990) Recurrent urticaria and reduced diamine oxidase activity. Clin Exp Allergy 20(4):373–376CrossRefPubMedGoogle Scholar
  12. Lieberman PL (2014) Idiopathic anaphylaxis. Allergy Asthma Proc 35(1):17–23MathSciNetCrossRefPubMedGoogle Scholar
  13. Lipińska-Opałka A, Wawrzyniak A, Lewicki S, Zdanowski R, Kalicki B (2017) Evaluation of immune indices and serum vitamin D content in children with atopic dermatitis. Adv Exp Med Biol. doi:10.1007/5584_2017_20
  14. Maintz L, Bieber T, Novak N (2006) Histamine intolerance in clinical practice. Dtsch Arztebl 103(51–52):A3477–A3483Google Scholar
  15. Maintz L, Novak N (2007) Histamine and histamine intolerance. Am J Clin Nutr 85:1185–1196PubMedGoogle Scholar
  16. Manzotti G, Breda D, Di Gioacchino M, Burastero SE (2016) Serum diamine oxidase activity in patients with histamine intolerance. Int J Immunopathol Pharmacol 29(1):105–111CrossRefPubMedGoogle Scholar
  17. Millichap J, Yee M (2003) The diet factor in pediatric and adolescent migraine. Pediatr Neurol 28(1):9–15CrossRefPubMedGoogle Scholar
  18. Mušič E, Korošec P, Šilar M, Adamič K, Košnik M, Rijavec M (2013) Serum diamine oxidase activity as a diagnostic test for histamine intolerance. Wien Klin Wochenschr 125(9–10):239–243PubMedGoogle Scholar
  19. Rosell-Camps A, Zibetti S, Pérez-Esteban G, Vila-Vidal M, Ferrés-Ramis L, García-Teresa-García E (2013) Histamine intolerance as a cause of chronic digestive complaints in pediatric patients. Rev Esp Enferm Dig 105:201–206CrossRefPubMedGoogle Scholar
  20. Sala-Cunill A, Cardona V (2015) Biomarkers of anaphylaxis, beyond tryptase. Curr Opin Allergy Clin Immunol 15(4):329–336CrossRefPubMedGoogle Scholar
  21. San Mauro Martin I, Brachero S, Garicano Vilar E (2016) Histamine intolerance and dietary management: a complete review. Allergol Immunopathol (Madr) 44(5):475–483CrossRefGoogle Scholar
  22. Schwelberger HG, Ahrens F, Fogel WA, Sánchez-Jiménez F (2013) Histamine metabolism. In: Stark H (ed) Histamine H4 receptor: a novel drug target in Immunoregulatory and inflammatory diseases. Versita, London, pp 63–101Google Scholar
  23. Skypala IJ, Williams M, Reeves L, Meyer R, Venter C (2015) Sensitivity to food additives, vaso-active amines and salicylates: a review of the evidence. Clin Transl Allergy 5:34. doi:10.1186/s13601-015-0078-3 CrossRefPubMedPubMedCentralGoogle Scholar
  24. Smolinska S, Jutel M, Crameri R, O’Mahony L (2014) Histamine and gut mucosal immune regulation. Allergy 69(3):273–281CrossRefPubMedGoogle Scholar
  25. Vadas P (2016) The platelet-activating factor pathway in food allergy and anaphylaxis. Ann Allergy Asthma Immunol 117:455–457CrossRefPubMedGoogle Scholar
  26. Vitte J (2015) Human mast cell tryptase in biology and medicine. Mol Immunol 63:18–24CrossRefPubMedGoogle Scholar
  27. Wantke F, Gotz M, Jarisch R (1994) The red wine provocation test: intolerance to histamine as a model for food intolerance. Allergy Proc 15:27–32CrossRefPubMedGoogle Scholar
  28. Wantke F, Götz M, Jarisch R (1993) Histamine-free diet: treatment of choice for histamine-induced food intolerance and supporting treatment for chronic headaches. Clin Exp Allergy 23(12):982–985CrossRefPubMedGoogle Scholar
  29. Weidenhiller M, Layritz C, Hagel AF, Kuefner M, Zopf Y, Raithel M (2012) Histamine intolerance syndrome (HIS): plethora of physiological, pathophysiological and toxic mechanisms and their differentiation. Z Gastroenterol 50(12):1302–1309CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG  2017

Authors and Affiliations

  • Joanna Kacik
    • 1
  • Barbara Wróblewska
    • 2
  • Sławomir Lewicki
    • 3
  • Robert Zdanowski
    • 3
  • Bolesław Kalicki
    • 1
  1. 1.Department of Pediatrics, Pediatric Nephrology and AllergologyMilitary Institute of MedicineWarsawPoland
  2. 2.Department of Immunology and Food MicrobiologyInstitute of Animal Reproduction and Food Research, Polish Academy of SciencesOlsztynPoland
  3. 3.Department of Regenerative Medicine and Cell BiologyMilitary Institute of Hygiene and EpidemiologyWarsawPoland

Personalised recommendations